Kozak & Associates’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Kozak & Associates's JNJ Position: Q3 2026 in Review
Kozak & Associates reduced its Johnson & Johnson (JNJ) stake by 0.33% in Q3 2026, selling an estimated $1.06K and leaving 1,215 shares worth $329K. The position accounts for 0.06% of the portfolio, ranked #61.
Kozak & Associates first reported a position in JNJ in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.16M in Q4 2022. 4,243 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.
- Kozak & Associates held 1,215 shares of Johnson & Johnson worth $329K as of Q3 2026.
- Kozak & Associates sold 4 Johnson & Johnson shares in Q3 2026, an estimated $1.06K.
- Johnson & Johnson made up 0.06% of Kozak & Associates's portfolio in Q3 2026, its #61 holding.
- Kozak & Associates first reported a position in Johnson & Johnson in Q4 2020 and has held it in 22 quarters since.
- Kozak & Associates's Johnson & Johnson position peaked at $1.16M in Q4 2022.
- 4,243 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.
Based on Kozak & Associates's 13F filing for Q3 2026, filed 29 Oct 2026.